Product
Supplier
Encyclopedia
Inquiry
Bedaquiline FuMarate buy - large image1
Bedaquiline FuMarate buy - image1

Bedaquiline FuMarate

GMP COA 5 Inquiries

Unit Price: Get Latest Price
CAS No.:

845533-86-0

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shanghai

Brand:

Simcere

Packaging:

5kg/Cardboard Drum

Sample Available:

Yes

Price valid (until):

2025-01-31

Company Type:
Manufactory
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
30 days
Qualification:
Main Products:

Diosmectite,Bedaquiline FuMarate,Iguratimod,Edoxaban Tosylate,Edaravone,Borneol

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Effects and efficacy:

    This product is used as part of combined therapy for the treatment of multidrug-resistant tuberculosis (MDR-TB) in adults and adolescents (12 to <18 years old and weighing ≥30 kg). This product can only be used when no other effective treatment options are available.

    Dosage and administration:


    The recommended dose for adults and adolescents (12 to <18 years old and weighing ≥30 kg): The recommended dose of this product is 400 mg orally, once a day, for 2 weeks; then 200 mg, 3 times a week, for 22 weeks (at least 48 hours between each dose) (the total duration of treatment is 24 weeks). The same drugs produced by different manufacturers may have inconsistent instructions. The above content is referenced from the instructions for Bedaquiline Fumarate Tablets (National Medicine Standard HJ20171366). If you find inconsistencies in the instructions before taking the drug, please consult a doctor or pharmacist in time.

    Adverse reactions:
    Serious adverse reactions: death, abnormal heart rhythm and/or hepatitis; other adverse reactions: nausea, joint pain, headache, hemoptysis, chest pain, loss of appetite, rash, increased blood amylase. If serious adverse reactions occur, seek medical attention immediately

    Items Specifications
    form  Powder
    color  White to off-white
    storage temp.  Inert atmosphere,Room Temperature
    ECHEMI Editorial Reference
    Bedaquiline fumarate is a fumarate salt prepared from equimolar amounts of bedaquiline and fumaric acid. It is used in combination therapy for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria. It has a role as an antitubercular agent and an ATP synthase inhibitor. It contains a bedaquiline(2+).

    Certificates

    Basic Info
    Product Name:

    Bedaquiline fumarate

    Other Name:

    (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol fumarate;(1R,2S)-1-(6-Bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenyl-2-butanol (2E)-2-butenedioate (1:1);Bedaquiline Fumarate salt;R 403323;(1R,2S)-1-(6-broMo-2-Methoxyquinolin-3-yl)-4-(diMethylaMino)-2-naphthalen-1-yl-1-phenylbutan-2-ol,(E)-but-2-enedioic acid;TMC-207;TMC207;TMC 207;(1R,2S)-1-(6-bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthalenyl)-1-phenyl-2-butanol;R207910 fumarate

    CAS No.:

    845533-86-0

    Molecular Formula:

    C36H35BrN2O6

    InChIKeys:

    ZLVSPMRFRHMMOY-KZDJUSSONA-N

    Molecular Weight:

    671.59

    Exact Mass:

    670.16785

    EC Number:

    605-001-5

    UNII:

    P04QX2C1A5

    Color/Form:

    White to off-white

    ATC Code:

    J04AK05

    Categories:

    Antibiotics

    Characteristics
    Critical Temperature & Pressure:

    Inert atmosphere,Room Temperature

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Diosmectite,Bedaquiline FuMarate,Iguratimod,Edoxaban Tosylate,Edaravone,Borneol

    Location:

    No. 109, Changfenghe Road, Jiangbei New District, Nanjing

    Payment Terms:

    100% TT in advance

    Average lead Time:

    30 days

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2022

    Simcere Pharmaceutical Group Limited (2096.HK) is a pharmaceutical company driven by innovative R&D. We are committed to "providing today's patients with medicines of the future" across the following core therapeutic areas: oncology, central nervous system, autoimmunity and anti-infection. Furthermore, we are also actively expanding our presence in disease areas with significant clinical needs in the future.

    Our industry-leading capabilities and commitment to synergistic innovation have also enabled various strategic collaborations and we are seen as the partner of choice by innovative biopharmaceutical companies, medical institutes, and research teams in China and globally.
  • Inquiry History
    5 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    BEDAQUILINE FUMARATE

    50 KG Feb 8, 2024
    South Korea

    cas845533-86-0 Bedaquiline fumarate

    1 KG Aug 4, 2026
    India

    Bedaquiline Fumarate

    100 KG Nov 13, 2025
    India

    BEDAQUILINE FUMARATE

    50 KG Apr 28, 2024
    India

    Bortezomib

    100.00 G Jul 30, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.